Finance

Lists
300573:SHE
Shenyang Xingqi Pharmaceutical Co Ltd
CN¥33,33
-1,80%
(-0,61) 1D
14 Okt., 15:04:07 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300573...
Open
CN¥33,80
High
CN¥33,88
Low
CN¥33,23
Mkt. cap
12,05 mjd
Avg. vol.
4,41 m
Volume
3,42 m
Dividend
2,97%
Quarterly dividend
CN¥0,25
Ex-dividend date
23 Sep. 2026
P/E ratio
15,07
52-wk high
CN¥59,07
52-wk low
CN¥33,23
EPS
CN¥2,21
Shares outstanding
354,92 m
No. of employees
2 k
Open
CN¥33,80
High
CN¥33,88
Low
CN¥33,23
Mkt. cap
12,05 mjd
Avg. vol.
4,41 m
Volume
3,42 m
Dividend
2,97%
Quarterly dividend
CN¥0,25
Ex-dividend date
23 Sep. 2026
P/E ratio
15,07
52-wk high
CN¥59,07
52-wk low
CN¥33,23
EPS
CN¥2,21
Shares outstanding
354,92 m
No. of employees
2 k
News stories
From web sources and news partners
About Shenyang Xingqi Pharmaceutical Co Ltd
CEO-
Employees2,4 k
Founded24 Mrt. 1977
Headquarters-
SectorPharmaceutical industry
Websitesinqi.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
740,99 m
569,12 m
683,34 m
717,54 m
Cost of goods sold
123,12 m
122,47 m
122,64 m
125,94 m
Cost of revenue
123,12 m
122,47 m
122,64 m
125,94 m
Research and development expenses
63,36 m
70,79 m
84,47 m
76,83 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
230,42 m
264,11 m
241,35 m
252,92 m
Operating expense
286,99 m
351,25 m
331,32 m
338,13 m
Total operating expenses
410,12 m
473,72 m
453,96 m
464,08 m
Operating income
330,87 m
95,41 m
229,38 m
253,46 m
Other non operating income
-1,22 m
475,40 k
797,23 k
-1,14 m
EBT including unusual items
304,06 m
111,50 m
230,12 m
252,18 m
EBT excluding unusual items
330,73 m
93,98 m
230,10 m
254,28 m
Income tax expense
39,98 m
14,56 m
23,71 m
28,19 m
Effective tax rate
13,15%
13,05%
10,30%
11,18%
Other operating expenses
-10,95 m
20,05 m
4,96 m
7,76 m
Net income
264,08 m
96,95 m
206,41 m
223,99 m
Net profit margin
35,64%
17,03%
30,21%
31,22%
Earnings per share
-
-
-
-
Interest and investment income
462,25 k
399,40 k
408,35 k
453,55 k
Interest expense
-1,00 m
-631,22 k
-481,32 k
-195,66 k
Net interest expenses
-538,91 k
-231,82 k
-72,97 k
257,89 k
Depreciation and amortization charges
-
-
-
-
EBITDA
353,72 m
120,67 m
254,64 m
283,39 m
Gain or loss from assets sale
74,80 k
-52,54 k
-
-7,97 k
AI content may include mistakes. Learn more
Google-programme